Q1 2025 Earnings Call Transcript February 13, 2025 cbdMD, Inc. misses on earnings expectations. Reported EPS is $-216.47441 ...

cbdMD Inc (YCBD) reports its first-ever positive net income and non-GAAP adjusted EBITDA, while becoming debt-free and maintaining strong gross margins. Charlotte, North Carolina--(Newsfile Corp ...

Charlotte, North Carolina--(Newsfile Corp. - February 13, 2025) - (NYSE American: YCBD) (NYSE American: YCBDpA), one of the ...

Total net sales for Q1 2025 were $5.1 million, reflecting a 12% sequential increase from the prior quarter. E-commerce sales contributed $3.9 million, representing 77% of total net sales, while ...

Maxim Group analyst Anthony Vendetti maintained a Buy rating on cbdMD (YCBD – Research Report) today and set a price target of $2.00. The ...

cbdMD Reduces Operating Loss, Reports Positive Net Income For Q3 And 15% YoY Drop In Net Sales cbdMD, Inc. (NYSE: YCBD), an operator of the leading CBD brands cbdMD and Paw CBD, along with its new ...

Charlotte, North Carolina--(Newsfile Corp. - January 15, 2025) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), a leading and highly trusted CBD company known for its flagship brands ...

Q1 2025 Earnings Conference Call February 13, 2025 4:20 PM ETCompany ParticipantsBrad Whitford - Chief Accounting ...

cbdMD, Inc. engages in the business of operating cannabidiol brands such as Paw cannabidiol and cbdMD botanicals. Its product categories include CBD tinctures, gummies, topical, and bath bombs.